Ophelia in the news
Find out what people are saying about the gold standard of treatment for opioid use disorder.
Press releases
July 28, 2023
Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use DisorderJAMA Network
May 9, 2023
DEA Extends Telehealth Flexibilities 6 Months in a Win for Behavioral Health AdvocatesBehavioral Health Business
April 17, 2023
Telehealth Supports Opioid Use Disorder Patient Retention in TreatmentmHealth Intelligence
April 14, 2023
Ophelia, CareSource, Gateway: Investing in Community Can ‘Start Moving the Needle’ on SUD TreatmentBehavioral Health Business
April 12, 2023
Study: More OUD Patients Stay in Treatment When Offered Buprenorphine via TelemedicineMedCity News
April 12, 2023
Study: More Opioid Addiction Patients Stay in Treatment When Offered Buprenorphine via TelemedicineCision PR Newswire
April 7, 2023
Ophelia Adds to C-Suite; Brightline Taps New Chief Clinical OfficerBehavioral Health Business
March 30, 2023
Ophelia Drafts Former Babylon, Omada Execs in Leadership Team ExpansionCision PR Newswire
March 21, 2023
'This could actually be catastrophic’: What the end of the public health emergency means for telehealthFast Company
March 21, 2023
'The Stakes Couldn’t Be Higher’: How DEA’s Proposal Will Affect Telehealth Controlled Substance PrescribingMedCity News
December 19, 2022
Virtual MAT Sees Much Higher Retention Than Industry Averages, Companies FindBehavioral Health Business
November 23, 2022
Expanding Treatment Options for Opioid Use Disorder with Ophelia Founder Zack GrayDecoding Healthcare Innovation Podcast